Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2015

Jan 10, 2015

33819_dirs_2015-01-09_6b4ab2a0-a41a-46c2-a37b-896655c85ad6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2015-01-08

Reporting Person: SCHIFFMAN GREGORY T (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-08 Common Stock A 178000 $0.00 Acquired 528000 Direct
2015-01-08 Common Stock A 250000 $0.00 Acquired 778000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4419 Indirect

Footnotes

F1: Restricted stock units, with 1/3 vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018.

F2: Includes (1) 262,500 restricted stock units, with 87,500 of these vesting on each of January 1, 2016, January 1, 2017, and January 1, 2018; and (2) 178,000 restricted stock units, with 59,333 of these vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018.

F3: Restricted stock units, with performance based vesting set by the issuer's Board of Directors and tied to the timely and successful conduct and completion of the issuer's Phase II clinical studies in dry AMD and spinal cord injury.

F4: Includes (1) 262,500 restricted stock units, with 87,500 of these vesting on each of January 1, 2016, January 1, 2017, and January 1, 2018; and (2) 178,000 restricted stock units, with 59,333 of these vesting on each of January 8, 2016, January 8, 2017, and January 8, 2018; and (3) 250,000 restricted stock units with performance based vesting.

F5: Shares held in 401(k) account in accordance with issuer's employer-match policies.